Home › Urogenital Cancer › Ohio › Columbus
Urogenital Cancer clinical trials in Columbus, OH
5 studies for Urogenital Cancer are looking for participants at sites in and around Columbus (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RecruitingPhase 2
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- Columbus Oncology and Hematology Associates Inc, Columbus
- and 11 more
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
RecruitingObservational study
- Ohio State University, Columbus
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
RecruitingPhase 1/2
- The Ohio State University Comprehensive Cancer Center, Columbus
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
RecruitingPhase 1
- The Ohio State University Comprehensive Cancer Center, Columbus
Feasibility Study of CBCT for IGRT in Cancer Patients
Recruiting
- James Outpatient Center, Columbus
- Ohio State University, Brain and Spine Hospital, Columbus
- The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus
- and 1 more
Urogenital Cancer trials in other cities
- Washington, DC6 studies
- Houston, TX6 studies
- Nashville, TN5 studies
- Durham, NC4 studies
- Ann Arbor, MI3 studies
- Atlanta, GA3 studies
- Cedar Rapids, IA3 studies
- St. Louis, MO3 studies
- Orange, CA3 studies
- Los Angeles, CA3 studies
- Omaha, NE3 studies
- Boston, MA3 studies
Other studies in Columbus
- Non-Small Cell Lung Cancer57 studies
- Breast Cancer40 studies
- Ovarian Cancer39 studies
- Cancer (all types)38 studies
- Lung Cancer37 studies
- Acute Myeloid Leukemia35 studies
- Chronic Lymphocytic Leukemia28 studies
- Metastatic Cancer27 studies
- Endometrial Cancer25 studies
- Prostate Cancer24 studies
- Multiple Myeloma24 studies
- Colorectal Cancer24 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.